Fever News and Research

RSS

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Colgate's Bright Smiles, Bright Futures national campaign to improve children's oral health joins Super Bowl champions Jonathan Vilma, Pierre Thomas, and Marques Colston and the Boys & Girls Clubs of Southeast Louisiana and Boys & Girls Clubs of the Gulf Coast, to host festivals highlighting the importance of maintaining good oral health. More than 600 children in New Orleans and Mississippi's Hancock and Harrison Counties will receive free dental screenings, oral health education and treatment referrals this weekend. They will also join New Orleans Saints Vilma, Thomas, and Colston in a brush-a-thon to promote oral health awareness.

9 Jul 2010

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

There is plenty to worry about when it comes to the job of parenting. However, wondering if a child is receiving the correct amount of over-the-counter (OTC) medication can now be a concern of the past, thanks to Children's AccuDial(R), a patented new line of children's medication available across Canada, with a dosing system based on body weight, not age.

9 Jul 2010

Brain fever mistaken as migraine kills a 30 year old woman

Jane Harrop, a 30 year old British woman was complaining of headaches for several days that made her feel “drunk”. She was diagnosed to be suffering from migraine but died two days later from a viral infection of the brain.

7 Jul 2010

Bacteria that will kill Dengue bearing mosquitoes on the way

Dengue is a deadly viral fever spread by mosquito bites that kills thousands around the world each year. Now researchers from James Cook University and University of Queensland are working on a bacterium called Wolbachia that can stop the spread of this virus.

6 Jul 2010

Update on suspected Acute Haemorrhagic Fever in Republic of the Congo

Blood samples taken from one of the suspected cases in Sangha Region, Republic of Congo, tested negative for several viral haemorrhagic fevers (Ebola, Marburg, CCHF, Arenavirus).

5 Jul 2010

Pet reptiles can pose health risks in the young: Report

A four month old girl, the report says, contracted salmonella infection after coming in contact with an eastern bearded dragon. She was taken to an ACT hospital emergency department last year suffering from fever, vomiting and bloody diarrhea. She had to be subsequently hospitalized for four days. The infection did not spread to any other family member the doctors wrote.

4 Jul 2010

USPTO grants Semafore method patent for PI3K inhibitors

Semafore Pharmaceuticals today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,745,485 entitled "Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways." This patent covers methods of inhibiting the spread of cancer in patients using phosphoinositide-3-kinase (PI3K) inhibitors alone or in combination with chemotherapeutic agents.

1 Jul 2010

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.

1 Jul 2010

SuperGen encouraged by Eisai's intent to file Dacogen sNDA for new indication

SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.

30 Jun 2010

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it's often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.

29 Jun 2010

Combination MMRV vaccine associated with increased risk of febrile seizures

The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox, according to a Kaiser Permanente Division of Research study appearing online in the journal Pediatrics. A febrile seizure is a brief, fever-related convulsion but it does not lead to epilepsy or seizure disorders, researchers explained.

28 Jun 2010

Extract of French maritime pine tree bark reduces hay fever symptoms

An estimated 60 million people in the U.S. are affected by allergic rhinitis, commonly known as hay fever, according to the American Academy of Allergy Asthma and Immunology. Hay fever is an allergic inflammation of the nasal airways that causes itching, swelling, mucus production, hives and rashes. A study published in the June 14, 2010 issue of Phytotherapy Research demonstrates Pycnogenol- (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, substantially improves the symptoms of hay fever.

24 Jun 2010

Researchers treat acute kidney injury using cells genetically reprogrammed to produce protein

A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.

23 Jun 2010

Scientists discover weakness of human louse

Scientists have discovered the human louse's Achilles' heel which could lead to new treatments to rid us of body and head lice infestations.

23 Jun 2010

International team obtains genome sequence of human body louse

An international team has obtained the genome sequence of the human body louse (Pediculus humanus humanus), a parasite that feeds on the blood of its host and a vector of pathogens that cause diseases such as epidemic typhus, relapsing fever and trench fever.

22 Jun 2010

New study that describes sequencing and analysis of body louse genome published

A global research team led by scientists from the J. Craig Venter Institute today published a new study in the Proceedings of the National Academy of Sciences describing the sequencing and analysis of the body louse genome. Lead author, Ewen Kirkness, Ph.D., JCVI, directed the sequencing and gene-finding efforts in the project. Detailed analysis of the genome was then conducted by a large international group of 71 scientists, coordinated by Barry Pittendrigh, University of Illinois, and Professor Evgeny Zdobnov, University of Geneva Medical School.

22 Jun 2010

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.

22 Jun 2010

Also in Global Health News: WHO scraps drug development group; Access to medication in Philippines; Yellow fever vaccine shortage; HIV-positive employee protection

Lancet World Report examines how "[d]isappointment over a long-awaited report on improving drug research and development for neglected diseases" led the WHO to form a new Consultative Expert Working Group (CEWG) to strategize around drug research and development. The formation of the new group comes after the report from the previous working group (EWG) was questioned due to "what some perceived to be a missed opportunity, unclear methods, a lack of transparency and signs of industry interference" and after "suspicions of impropriety" surfaced.

21 Jun 2010

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.

21 Jun 2010

Malaria rises as forests disappear: Study

Avid deforestation of the tropical forests is cited to be one of the reasons for the 50% increase in incidence of this disease in the surrounding areas according to a new research that is tracking deforestation in Brazil's Amazon.

18 Jun 2010

Fever News and Research

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Accudial's weight-based rotating labels prevent underdosing and overdosing in children's OTC medications

Brain fever mistaken as migraine kills a 30 year old woman

Bacteria that will kill Dengue bearing mosquitoes on the way

Update on suspected Acute Haemorrhagic Fever in Republic of the Congo

Pet reptiles can pose health risks in the young: Report

USPTO grants Semafore method patent for PI3K inhibitors

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

SuperGen encouraged by Eisai's intent to file Dacogen sNDA for new indication

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

Combination MMRV vaccine associated with increased risk of febrile seizures

Extract of French maritime pine tree bark reduces hay fever symptoms

Researchers treat acute kidney injury using cells genetically reprogrammed to produce protein

Scientists discover weakness of human louse

International team obtains genome sequence of human body louse

New study that describes sequencing and analysis of body louse genome published

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Also in Global Health News: WHO scraps drug development group; Access to medication in Philippines; Yellow fever vaccine shortage; HIV-positive employee protection

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

Malaria rises as forests disappear: Study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News